Catalent, Inc.
Catalent, Inc. (CTLT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CTLT · as of Jun 9, 2026
Key Statistics
Explore Catalent, Inc. Data
ctlt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 21 · Buy rate: 38.1%
The CTLT analyst consensus is Hold, based on ratings from 21 Wall Street analysts over the past 3 months. The average 12-month price target is $74.25, representing +16.97% upside from the current price of $63.48.
Competitors & Peers
ctlt competitorsCTLT
BDX
CERE
ITCI
KRTX
OSHStock Performance
Full HistoryAbout Catalent, Inc.
Catalent, Inc. operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical dru…
what is catalent, inc. · ctlt stock overview · catalent, inc. company profile · who is catalent, inc. ceo · ctlt NYSE · catalent, inc. headquarters · catalent, inc. business segments
About Stock Overview & Key Data
Catalent, Inc. (CTLT) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NYSE since Jul 31, 2014. As of the latest trading session, CTLT stock price is $63.48, with a market capitalization of $11.5B. The stock has returned +28.45% over the past 12 months and +0.00% year-to-date.
According to 21 Wall Street analysts, the consensus rating for Catalent, Inc. stock is Hold, with an average 12-month price target of $74.25. In fiscal year 2024, Catalent, Inc. reported revenue of $4.4B and net income of -$1.0B. For detailed data — including Catalent, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Catalent, Inc. (CTLT) stock price is $63.48. The stock is traded on NYSE under the ticker symbol CTLT. The 52-week range is $42.11 – $63.50.